Navigation Links
Oncolytics Biotech(R) Inc. Reports Highlights and Financial Results for 2008
Date:3/4/2009

---------------------- Revenue Rights revenue - - - 310,000 ------------------------------------------------------------------------- - - - 310,000 ------------------------------------------------------------------------- Expenses Research and development 13,351,875 12,385,743 11,378,998 74,531,777 Operating 4,311,575 3,826,195 3,630,144 24,837,025 Stock based compensation 64,039 539,156 403,550 4,768,844 Foreign exchange (gain) loss (68,283) 8,862 35,270 589,427 Amortization - intellectual property 361,500 361,500 361,500 3,434,250 Amortization - property and equipment 48,754 40,714 52,638 497,151 ------------------------------------------------------------------------- 18,069,460 17,162,170 15,862,100 108,658,474 ------------------------------------------------------------------------- Loss before the following 18,069,460 17,162,170 15,862,100 108,348,474 Interest income (519,256) (1,211,744) (1,233,809) (6,534,005) Gain on sale of BCY LifeSciences Inc. - - - (299,403) Loss on sale of Transition Therapeutics Inc. - - - 2,156,685 ------------------------------------------------------------------------- Loss before income taxes 17,550,204 15,950,426 14,628,291 103,671,751 Future income tax recovery - - - (1,115,000) ------------------------------------------------------------------------- Net lo
'/>"/>
SOURCE Oncolytics Biotech Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related biology technology :

1. Oncolytics Biotech Inc. Announces Issuance of 23rd U.S. Patent
2. Oncolytics Biotech Inc. Reports Positive Interim Results of U.K. Phase Ia/Ib Combination REOLYSIN(R) and Radiation Clinical Trial
3. Media Advisory - Oncolytics Biotech Inc. to Present at BioPartnering Europe
4. Media Advisory - Oncolytics Biotech Inc. to Present at BIO InvestorForum 2007
5. Oncolytics Biotech Inc. Announces Approval for U.K. Clinical Trial Investigating REOLYSIN(R) in Combination with Cyclophosphamide
6. Oncolytics Biotech Inc. Collaborators to Present Positive Interim Results of U.K. Phase Ia/Ib Combination REOLYSIN(R) and Radiation Clinical Trial
7. Oncolytics Biotech Inc. Announces 2007 Third Quarter Results
8. Media Advisory - Oncolytics Biotech Inc. to Present at Acumen BioFin Rodman & Renshaw 9th Annual Healthcare Conference
9. Media Advisory - Oncolytics Biotech Inc. to Present at Toronto CFA Society
10. Oncolytics Biotech Inc. Announces Issuance of 24th U.S. Patent
11. Oncolytics Biotech Inc. to Present at Annual Vaccine Production Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/17/2014)... Terracon Corporation has announced the introduction of a ... This addition to the company’s industry-leading line of custom ... available in 125 or 250 gallon capacities. It ... or less. , The new pre-engineered TerraPure tank offers ... TerraPure tank line – plus quick turnaround. An ...
(Date:9/17/2014)... , Sept. 17, 2014 /PRNewswire/ - SQI Diagnostics Inc. ... develops and commercializes proprietary technologies and products for advanced ... been approved for trading in the United ... is expected to commence on September 17, 2014 on ... continue to trade on the TSX Venture Exchange under ...
(Date:9/17/2014)... (PRWEB) September 17, 2014 Beckman ... advances science and healthcare, has renewed its agreement with ... As part of the agreement, Personify will continue to ... sustained emphasis on recruitment analytics, including time-to-fill, time-to-source and ... renew our agreement with Personify was based on the ...
(Date:9/17/2014)... The Pistoia Alliance, a global not ... to innovation in life sciences R&D through pre-competitive ... as Executive Director Business Development North America, as ... , Carmen joins the Pistoia Alliance from Accelrys ... Accelrys, she managed various life sciences and material ...
Breaking Biology Technology:Terracon Introduces Pre-Engineered TerraPure® Tank for Ultrapure Water Applications 2SQI Diagnostics to begin Trading on the OTCQX Marketplace in the United States 2SQI Diagnostics to begin Trading on the OTCQX Marketplace in the United States 3Beckman Coulter Signs 3-year RPO Contract with Personify 2Beckman Coulter Signs 3-year RPO Contract with Personify 3Pistoia Alliance Expands Business Development with Appointment of Carmen Nitsche 2
... Up in the sky. It's a bird. It's a plane. It's ... denial in a single bound. Indeed, lately the media has been ... to result from the mass exodus of Baby Boomers from the ... believe that this trend and its impacts on businesses are black ...
... Milwaukee, Wis. - The National Cancer Institute ... Medical College of Wisconsin to study the growth ... second successful renewal of the grant that was first awarded ... ongoing principal investigator. , ,She and other investigators are developing ...
... This is the ninth in a series of articles ... sectors. The most recent article focused on worker classification. ... The idea is developed. Lawyers and accountants are on ... is formed. The name has been chosen. Perhaps workers, ...
Cached Biology Technology:Shades of gray: Business impacts of an aging workforce 2Shades of gray: Business impacts of an aging workforce 3Shades of gray: Business impacts of an aging workforce 4Shades of gray: Business impacts of an aging workforce 5Shades of gray: Business impacts of an aging workforce 6Early Stage, Step 9: Raising capital in the securities landscape 2Early Stage, Step 9: Raising capital in the securities landscape 3Early Stage, Step 9: Raising capital in the securities landscape 4
(Date:9/17/2014)... of Spanish researchers have obtained the first partial genome ... century pig found at the site of the Montsoriu ... ancient pig is closely related to today,s Iberian pig. ... crossed with modern Iberian pigs. , The study, published ... aspects of pig species, and particularly on that of ...
(Date:9/17/2014)... in the human retinoblastoma protein gene are a leading ... have turned to fruit fly eyes to unlock the ... a paper featured on the cover of the current ... Michigan State University researchers provide the first detailed examination ... in the human cancer gene, said Irina Pushel, MSU ...
(Date:9/17/2014)... Washington, DC A team of researchers working on a ... that coral growth rates have plummeted 40% since the ... playing an important role in this perilous slowdown. ... peril facing coral reefs, the team compared current measurements ... Great Barrier Reef with similar measurements taken more than ...
Breaking Biology News(10 mins):Iberian pig genome remains unchanged after 5 centuries 2Abnormal properties of cancer protein revealed in fly eyes 2Coral growth rate plummets in 30-year comparison 2
... and American Board of Internal Medicine (ABIM) announce the ... performance evaluation tools for blood specialists. , ... ABIM certification, ASH and ABIM have co-developed the Hematology ... to complete their practice performance assessment requirement for recertification. ...
... research project which could revolutionise the diagnosis and treatment ... four-year project, the results of which are now being ... means of identifying the two most deadly forms of ... for practitioners. , The implications for improving children's health ...
... to ferns to create a novel energy scavenging device that ... provide a method for powering micro and nano devices with ... works," said Michel Maharbiz, assistant professor of electrical engineering and ... the device. "If you build these things they will move. ...
Cached Biology News:New tool helps blood specialists improve patient care 2Hope for major advance in fighting world killer disease 2Hope for major advance in fighting world killer disease 3Ferns provide model for tiny motors powered by evaporation 2
...
Tissue-Stat ( Tissue Adherent for Mounting Formalin-Fixed and Frozen Tissue Sections.)...
This monoclonal antibody specifically recognizes Y. pestiscapsular F1 antigen. It does not cross-react with Y. pseudotuberculosisor Y. enterocolitica....
Clarin Mounting Medium (Permanent environmentally safe mounting medium for general histology & cytology use)...
Biology Products: